Johns Hopkins University School of Medicine alumnus and former faculty member Hamilton O. Smith, M.D., whose 1978 Nobel Prize-winning discovery of restriction enzymes revolutionized genetic ...

Totipotent Cells: Often regarded as the "holy grail" of stem cell biology, these cells can develop into any type of cell in the body, offering vast possibilities for tissue regeneration.

A new West Coast biotech has emerged into the busy in vivo cell therapy space, this time with the backing of Nobel Prize-winning CRISPR pioneer Jennifer Doudna, Ph.D. Azalea Therapeutics has bloomed ...

2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: Regulus Therapeutics went up 120%; 89bio went up 85%; Chimerix gained 69% and ...

iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to a broad basket of industry-leading biotech equities. The fund's strategy ...

Evaxion Biotech ( ($EVAX) ) has shared an update. On November 3, 2025, Evaxion A/S announced the expansion of its R&D pipeline with the ...

Q3 2025 Earnings Call Transcript October 28, 2025 Operator: Thank you for standing by. Welcome to the Kiniksa Pharmaceuticals ...

The biotechnology market is entering a new growth phase, driven by the convergence of genomic science, artificial intelligence, and precision medicine.

Firn says its active ingredient, derived from organisms dormant since the Ice Age, significantly increases skin’s natural capacity for self-regeneration.

AI in Computer-Aided Synthesis Planning Market reached USD 2.13 bn in 2024 and is expected to grow rapidly to USD 68.06 bn by ...